The identified measures and practices put in place and implemented by the PRC have caused significant harm to Union manufacturers of medical devices that account for approximately 700000 jobs in the Union [medtech-europe--facts-figures-2024.pdf.]. The leverage that could be created by the IPI measure to remove the discriminatory barriers in the medical devices public procurement market in the PRC and remedy the serious and recurrent impairment of access from which Union economic operators suffer, could be beneficial, for Union manufacturers and thus for the creation of additional employment in the sector. Even in the case where these barriers would not be removed, the Commission has estimated that the expected substitution of imports from the PRC by medical devices manufactured in the Union would sustain the existing jobs in the sector and could potentially generate over 3000 new Union jobs [This estimation is based on the assumption made in recital 49 that ‘the Union medical devices producers could potentially capture around 60 % of the procurement volume that would have originated in the PRC in the absence of the IPI measure’ (i.e. 60 % of EUR 1-1,2 billion) and the productivity per employee in the Union estimated at EUR 177000 in 2024 (source: medtech-europe--facts-figures-2024.pdf).]. Therefore, the current IPI measure is expected to have an aggregate positive impact on the overall Union industrial output.
56 2. DETERMINATION OF THE IPI MEASURE › 2.3. Union interest › 2.3.3. Interest of the Union economy, Regulation (EU) 2025/1197
In forcesince 19 Jun 2025